PomDoctor Ltd. · NASDAQ:POM
PomDoctor — Investor Presentation (September 2026)
27 slides from PomDoctor's investor presentation, Sep 10, 2026
Slide 1: Building a Predictive Healthcare Data and Services Infrastructure
Building a Predictive Healthcare Data and Services Infrastructure
Slide 2: Forward-Looking Statements
Forward-Looking Statements This presentation contains forward-looking statements within the meaning of the federal securities laws. These statements are based on current expectations, assumptions, and projections regarding future events and operating performance and are subject to known and unknown
Slide 3: Confidentiality Agreement
Confidentiality Agreement This presentation contains confidential and proprietary information of POMDOCTOR Limited ("POM") and is provided solely for discussion purposes in connection with a potential financing or strategic partnership opportunity. The information contained herein may not be reprodu
Slide 4: Agenda
Agenda 01 Industry Transformation 02 Our Solution 03 Future Roadmap POM Leverages Technology and Business Model Innovation to Shape a New Future for Intelligent Healthcare 4
Slide 5: Industry Transformation: The Era of Predictive Healthcare
Industry Transformation: The Era of Predictive Healthcare Growing Chronic Disease Burden 1% Technological Paradigm Shift Healthcare Payment System Transformation Three Converging Trends Are Ushering in a New Era of Predictive Healthcare 5
Slide 6: Why Now? All the Key Elements Are in Place
Why Now? All the Key Elements Are in Place WHY NOW? INFLECTION POINT Technology, Hardware, and Payment Infrastructure are Creating Favorable Industry Conditions Healthcare AI Models Advances in deep learning algorithms and computing capabilities have enabled AI-assisted risk assessment based on tens
Slide 7: POM's Strategic Positioning: Building a Predictive Healthcare Data & Services Infrastructure
POM's Strategic Positioning: Building a Predictive Healthcare Data & Services Infrastructure • • • • POM Global Digital Healthcare Platform • Proactive health management services spanning the entire care journey and a wide range of use cases • A comprehensive health data ecosystem featuring continuo
Slide 8: From Passive Healthcare to Predictive Healthcare
From Passive Healthcare to Predictive Healthcare Traditional Medicine → Passive Treatment • Reactive Care with Limited Preventive Awareness • One-Time, Fragmented Care with Limited Ongoing Monitoring • Disconnected Data Across Healthcare Providers • 24/7 Real-Time Vital Sign Monitoring and Analysis
Slide 9: Core Growth Engine: Healthcare Intelligence Flywheel
Core Growth Engine: Healthcare Intelligence Flywheel A Virtuous Flywheel Reinforces Competitive Advantages — Each closed-loop service interaction enriches data assets, enhances AI capabilities, improves service intelligence, and supports sustainable long-term growth Wearables • Acquire Users and Gen
Slide 10: Wearable Devices: A Key Gateway to Healthcare Data
Wearable Devices: A Key Gateway to Healthcare Data 24/7 Continuous Vital Sign Monitoring By continuously capturing key health indicators such as blood pressure, heart rate, HRV, blood oxygen levels, and sleep cycles around the clock, wearable devices overcome traditional time and location constraint
Slide 11: AI Healthcare Engine: Powering Predictive Healthcare
AI Healthcare Engine: Powering Predictive Healthcare ! Abnormal Trend Prediction Leveraging time-series analysis and predictive algorithms to project future health trends, enabling proactive health management. Intelligent Closed-Loop Evolution — Continuous data feedback powers ongoing AI model impro
Slide 12: Current Progress & Key Operating Metrics
Current Progress & Key Operating Metrics Partner Physician Network 212,800+ Building a Broad Healthcare Service Collaboration Network Paying Patients 699,338+ Serving a Large Patient Base with Continued User Growth Total Prescriptions Processed 3.13 Million+ Growing Operational Scale and Improving S
Slide 13: Real-World Data (RWD) Barrier
Real-World Data (RWD) Barrier Physiological Data Continuous vital sign data, including heart rate, blood pressure, body temperature, and other key indicators, enables real-time tracking of changes in users' baseline health metrics and helps establish a comprehensive, around-the- clock view of physic
Slide 14: China Market: The Foundation of Global Expansion
China Market: The Foundation of Global Expansion CHINA DATA · Core Data Assets Built a large-scale repository of user behavioral data and real-world healthcare interaction records. OPS · Operational Excellence System Developed and optimized end-to-end service SOPs, validating strong execution capabi
Slide 15: USA Strategy: Strategic Beachhead at CES
USA STRATEGY · Strategic Beachhead Leveraging the CES Conference in January 2027 as a key milestone, the Company plans to formally launch its U.S. market strategy and publicly showcase its solutions. TARGET · Core Entry Point The Company plans to conduct its first public product showcase in the U.S.
Slide 16: Global Expansion Roadmap
Global Expansion Roadmap 2026 U.S. Market Preparation Preparing for the CES Conference, conducting market research, and establishing a local team to support U.S. market development. 2027 U.S. Market Launch Launch the U.S. market at CES, followed by the gradual development of healthcare services, pha
Slide 17: Four-Tier Revenue Structure with Diversified Revenue Streams
Four-Tier Revenue Structure with Diversified Revenue Streams Pharmaceutical Data Services (RWS/RWD) B2B Enterprise Services AI Membership Subscription B2C Basic Services 17
Slide 18: Core Moat: System-Level Barriers
Core Moat: System-Level Barriers Core Capabilities Traditional Internet Hospitals POM Yes Deeply Integrated (China) Robust Global Supply Chain Data-Driven Core Intelligence Engine Proprietary + Open Ecosystem Monitoring · Analytics · Care Delivery · Payment · Fulfillment POM is more than a single-se
Slide 19: Capital Raising Plan US$30 Million
Capital Raising Plan US$30 Million Planned Use of Proceeds 40% U.S. Market Expansion 25% AI & Data Infrastructure 20% Wearable Device Mass Production 15% Global Operations Infrastructure 19
Slide 20: Key Objectives for the Next Months
Key Objectives for the Next 18 Months 2026 Q3 U.S. Market Preparation Recruit key members of the U.S. team and initiate market research. 2026 Q4 Product & Channel Preparation Complete U.S. localization of wearable and RPM solutions and preparations for CES 2027. 2027 Q1 U.S. Market Launch at CES For
Slide 21: Financial Highlights
Financial Highlights Net Revenues RMB in Millions 304.9 342.6 399.9 FY2023 Audited FY2024 Audited FY2025 Audited Revenue Breakdown Note: Fiscal years ended December 31. 26.0% 74.0% 23.3% 76.7% FY2023 Audited FY2024 Audited Internet Hospital Pharmaceutical Supply Chain 37.7% 62.3% FY2025 Audited 21
Slide 22: Financial Highlights
Financial Highlights 38.7 47.7 52.3 FY2023 Audited FY2024 Audited FY2025 Audited Net Loss 36.9 37.4 130.9 FY2023 Audited FY2024 Audited FY2025 Audited Gross Profit and Gross Margin RMB in Millions RMB in Millions 13.1% Gross margin in % 12.7% 13.9% Note: Fiscal years ended December 31. 22
Slide 23: From Reactive Care to Predictive Healthcare
From Reactive Care to Predictive Healthcare POM 23
Slide 24: Appendix: Core Disclosures & Management Team
Appendix (for Roadshow Reference) Core Disclosures & Management Team • Management Team Backgrounds & Board Structure Contact Us Investor Relations Email: [email protected] Project Inquiries: +86 020-6231 2277 24
Slide 25: Corporate Structure
Corporate Structure 100% 80% POMDOCTOR LIMITED (Cayman Islands) POMEGRANATE CLOUD MEDICAL LIMITED (Hong Kong) Guangzhou Pomegranate Cloud Medical Health Medical Technology Co., Ltd. Guangzhou Qilekang Digital Health Medical Technology Co., Ltd. (VIE) Guangzhou Qilekang Modern Pharmaceutical Logistic
Slide 26: Management
Management • Mr. Shi is our co-founder and chief executive officer, and has served as the chairman of the board of directors since our inception. • Mr. Shi has more than a decade of entrepreneurial experience in the healthcare and Internet industries. • Mr. Shi has received Liwan District Medical an
Slide 27: Board of Directors
Board of Directors Zhenyang Shi Chairman, Chief Executive Officer • Ms. Jing has served as a managing director at Galaxy Capital since 2019, and served as a partner of Haichuanghui, a subsidiary of Haier Group Corporation, from 2017 to 2019. • Ms. Jing served as a vice president of the human resourc